Added value of mindfulness in a digital cannabis intervention: Three-arm randomized trial
In brief
Mindfulness-enhanced digital program halves cannabis use days versus standard therapy at six months
In a trial of 301 frequent cannabis users, those assigned to mindfulness-enhanced digital therapy reported about half as many use days at six months as those receiving standard digital cognitive behavioral therapy. Both programs reduced use at six weeks compared with a waitlist, but low retention and reliance on assumptions about missing data temper confidence in the longer-term result.
- Journal
- Internet interventions (Q1)
- Published
- 3 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Nikolaos Boumparis, Severin Haug, Christian Baumgartner, Andreas Wenger, Doris Malischnig, Michelle Dey, et al.
- PMID
- 43022881
- DOI
- 10.1016/j.invent.2026.101021
Why clinicians should know about it
- Picked for Psychiatry and Mental Health (top studies of the week, 15 November 2026): Randomized digital CBT trial for cannabis use with mood outcomes
Abstract
PURPOSE: Digital interventions for cannabis use typically produce small short-term effects that fade over time. This three-arm randomized controlled trial examined whether integrating mindfulness into an established digital cognitive behavioural therapy (CBT) self-help intervention improves the durability of outcomes. METHODS: We randomized 301 frequent adult cannabis users to Mindfulness CANreduce (mindfulness-enhanced CBT), Standard CANreduce (CBT only), or a waitlist control group with continued access to care as usual. The primary outcome was self-reported cannabis use days in the past 30 days, assessed at 6 weeks, 3 months, and 6 months, and analysed on an intention-to-treat basis using zero-inflated negative binomial mixed models with multiple imputation. MAIN RESULTS: Retention was 51.8% at 6 weeks and 31.6% at 6 months, and 6-month attrition did not differ across groups. At 6 weeks, both active interventions reduced cannabis use days relative to the control group (IRR = 0.76, 95% CI [0.64, 0.90]; IRR = 0.80, 95% CI [0.67, 0.95]). At 6 months, the Mindfulness CANreduce group reported fewer use days than both the Standard CANreduce group (IRR = 0.52, 95% CI [0.43, 0.64]) and the control group (IRR = 0.46, 95% CI [0.38, 0.56]), with greater improvements in depressive and anxiety symptoms. Complete-case and tipping-point sensitivity analyses supported these findings, which remain conditional on assumptions about the missing data. CONCLUSION: Integrating mindfulness into a fully automated digital intervention was associated with more durable reductions in cannabis use. Given the low retention and engagement, these findings should be interpreted cautiously.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.